Cleared Traditional

K172027 - Adani MammoScan

K172027 is the FDA 510(k) clearance for Adani MammoScan by Adani. It is a Class 2 Radiology device (product code MUE) cleared through the Traditional 510(k) pathway after a 107-day FDA review.

K172027 · Adani · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2017
Decision
107d
Days
Class 2
Risk

K172027 is an FDA 510(k) clearance for the Adani MammoScan. Classified as Full Field Digital, System, X-ray, Mammographic (product code MUE), Class II - Special Controls.

Submitted by Adani (Minsk, BY). The FDA issued a Cleared decision on October 20, 2017 after a review of 107 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1715 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Adani devices

Submission Details

510(k) Number K172027 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 05, 2017
Decision Date October 20, 2017
Days to Decision 107 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
At panel average
Panel avg: 107d · This submission: 107d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MUE Full Field Digital, System, X-ray, Mammographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1715
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUE Full Field Digital, System, X-ray, Mammographic

All 39
Devices cleared under the same product code (MUE) and FDA review panel - the closest regulatory comparables to K172027.
Mammomat Revelation
K173408 · Siemens Medi Cal Solutions, Inc. · Mar 2018
SenoBright HD
K172404 · Ge Healthcare · Oct 2017
ASPIRE Cristalle
K173132 · Fujifilm Medical Systems U.S.A, Inc. · Oct 2017
Senographe Pristina
K163302 · Ge Healthcare · Sep 2017
Mammomat Fusion with Stereotactic Biopsy
K163252 · Siemens Medical Solutions USA, Inc. · Jan 2017
Senographe Pristina
K162268 · Ge Healthcare · Nov 2016